Peer-reviewedCC BYJournal of translational autoimmunity
Targeting the NLRP3 inflammasome in immune cells: A new frontier in autoimmune disease research
- 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- 2Department of Immunology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Related
- Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- Curcumin Improves Silica Induced Lung Fibrosis by Targeting TLR4-NLRP3 Inflammasome and TGF-β Inhibition in Mice Model.
- NLRP3 inflammasome-driven inflammation as a cause of atrial fibrillation: potential synergistic inhibition of the NLRP3 via upstream magnesium repletion and targeting NLRP3 with a downstream inhibitor
- Mechanisms by which interleukin-18 binding protein regulates the NLRP3 inflammasome in Kawasaki disease-related coronary artery lesions
- Sex and disease differences in patients’ diagnostic experiences in autoimmune diseases: an international cross-sectional study
BibTeX
@article{asefpour2026targeting,
title = {{Targeting the NLRP3 inflammasome in immune cells: A new frontier in autoimmune disease research}},
author = {Aysan Asefpour and Shiva Alipour and Sepideh Sohrabi and Yasser Bagheri and Leili Aghebati-Maleki},
journal = {Journal of translational autoimmunity},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13742504},
note = {CC BY},
}
RIS
TY - JOUR
TI - Targeting the NLRP3 inflammasome in immune cells: A new frontier in autoimmune disease research
AU - Aysan Asefpour
AU - Shiva Alipour
AU - Sepideh Sohrabi
AU - Yasser Bagheri
AU - Leili Aghebati-Maleki
PY - 2026
DA - 2026/10/22
JO - Journal of translational autoimmunity
UR - https://europepmc.org/article/PMC/PMC13742504
SN - 2589-9090
ER -